NFKB1 and cancer: MSCs play a critical role in cancer development and therapy by mediating interactions with malignant cells through multiple signaling pathways, such as WNT/β-catenin, nuclear factor kappa B (NF-κB), and transforming growth factor beta (TGF-β).